5 Best Debt Free Stocks to Buy Right Now

Page 1 of 5

In this article, we will list the 5 Best Debt Free Stocks to Buy Right Now. Please visit 8 Best Debt Free Stocks to Buy Right Now if you would like to see the extended list and the methodology behind it.

Why Okta, Inc. (OKTA) Crashed Last Week

5. Globus Medical, Inc. (NYSE:GMED)

On March 18, 2026, Wells Fargo assumed coverage of Globus Medical, Inc. (NYSE:GMED) with an Overweight rating and a $104 price target, while maintaining its rating, price target, and estimates.

Last month, Globus Medical, Inc. (NYSE:GMED) reported fourth-quarter EPS of $1.28, above the 96c consensus estimate, with revenue of $826.4M compared to the $803.29M consensus. Chief Executive Officer Keith Pfeil said momentum “accelerated in the fourth quarter,” pointing to double-digit sales and earnings growth and expansion across the company’s portfolio, including its spine business, supported by disciplined execution. Pfeil added that the company is focused on sustaining growth through product launches, expanding its sales force, and improving outcomes through its surgical ecosystem.

Globus Medical, Inc. (NYSE:GMED) raised its FY26 EPS outlook to $4.40-$4.50 from $4.30-$4.40, above the $4.24 consensus, and expects FY26 revenue of $3.18B-$3.22B compared to the $3.16B consensus.

Globus Medical, Inc. (NYSE:GMED) develops and commercializes healthcare solutions for musculoskeletal disorders globally.

Page 1 of 5